INmune Bio shareholders back amended 2021 stock incentive plan, boosting share pool to 9,158,525

• INmune Bio held its annual shareholder meeting on June 16, 2026.
• Shareholders adopted an amended 2021 Stock Incentive Plan, lifting the plan’s share pool to 9,158,525 shares from 6,500,000.
• Shareholders also authorized an evergreen provision to automatically increase reserved shares each year from 2027 through 2031, subject to board limits.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. INmune Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-069611), on June 17, 2026, and is solely responsible for the information contained therein.